Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99
Titel:
Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99
Auteur:
Pagani, O. Klingbiel, D. Ruhstaller, T. Nolè, F. Eppenberger, S. Oehlschlegel, C. Bernhard, J. Brauchli, P. Hess, D. Mamot, C. Munzone, E. Pestalozzi, B. Rabaglio, M. Aebi, S. Ribi, K. Rochlitz, C. Rothgiesser, K. Thürlimann, B. von Moos, R. Zaman, K. Goldhirsch, A.